MedTrace Logo

A Study on the Diagnostic Value of the Methacholine Choline Provocation Test in the Asthmatic Population

NCT05870436 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1100

Last updated 2023-05-23

No results posted yet for this study

Summary

This study was a multicenter, open, observational study and was divided into two stages; Stage I study includes patients with suspected asthma to observe the diagnostic value and safety of Methacholine Choline Provocation Test. All patients clinically evaluated for bronchial provocation testing were included in the stage II study to further validate the diagnostic value and cutoff value of the methacholine choline provocation test.

Conditions

Interventions

DIAGNOSTIC_TEST

Methacholine Choline Provocation Test

Perform methacholine choline provocation test according to the protocol

Sponsors & Collaborators

  • Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

    collaborator INDUSTRY

  • jingping Zheng

    lead OTHER

Principal Investigators

  • yi Gao, PhD · The First Hospital of Guangzhou Medical University

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-19
Primary Completion
2025-01-31
Completion
2025-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05870436 on ClinicalTrials.gov